| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |